Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

ý              QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2003

 

Commission File No. 0-16614

 

NEORX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Washington

 

91-1261311

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer Identification No.)

 

300 Elliott Avenue West, Suite 500, Seattle, Washington 98119-4114

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (206) 281-7001

 

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes

 

ý

 

No

 

o

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act. 

 

Yes

 

o

 

No

 

ý

 

As of November 7, 2003, 27,943,132 shares of the Registrant’s common stock, $.02 par value per share, were outstanding.

 

 



 

TABLE OF CONTENTS

 

QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2003

 

PART I
FINANCIAL INFORMATION
 
 

Item 1.

Financial Statements (Unaudited):

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2003 and December 31, 2002

 

 

 

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2003 and 2002

 

 

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2003 and 2002

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Results of Operations and Financial Condition

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

 

PART II
OTHER INFORMATION
 
 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

Signatures

 

 

 

Exhibit Index

 

2



 

PART I.  FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

(unaudited)

 

 

 

September 30, 2003

 

December 31, 2002

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

2,390

 

$

6,564

 

Investment securities

 

13,350

 

9,572

 

Prepaid expenses and other current assets

 

955

 

1,269

 

Total current assets

 

16,695

 

17,405

 

 

 

 

 

 

 

Facilities and equipment, net

 

8,117

 

8,509

 

Other assets, net

 

67

 

79

 

 

 

 

 

 

 

Total assets

 

$

24,879

 

$

25,993

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

653

 

$

1,024

 

Accrued liabilities

 

832

 

1,674

 

Current portion of note payable

 

348

 

512

 

Total current liabilities

 

1,833

 

3,210

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

Note payable, net of current portion

 

5,062

 

5,182

 

Asset retirement obligation

 

514

 

 

Other

 

 

25

 

Total long-term liabilities

 

5,576

 

5,207

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred stock, $.02 par value, 3,000,000 shares authorized:

 

 

 

 

 

Convertible preferred stock, Series 1, 205,340 shares issued and outstanding at September 30, 2003 and December 31, 2002 (entitled in liquidation to $5,300 and $5,175, respectively, at September 30, 2003 and December 31, 2002)

 

4

 

4

 

Common stock, $.02 par value, 60,000,000 shares authorized, 27,696,623 and 26,765,082 shares issued and outstanding at September 30, 2003 and December 31, 2002, respectively

 

554

 

535

 

Accumulated other comprehensive income – unrealized loss on investment securities

 

(19

)

(101

)

Additional paid-in capital

 

226,115

 

224,035

 

Accumulated deficit

 

(209,184

)

(206,897

)

  Total shareholders’ equity

 

17,470

 

17,576

 

Total liabilities and shareholders’ equity

 

$

24,879

 

$

25,993

 

 

See accompanying notes to the condensed consolidated financial statements.

 

3



 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

225

 

$

507

 

$

10,531

 

$

2,036

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

2,037

 

4,438

 

7,376

 

17,472

 

General and administrative

 

1,142

 

1,535

 

4,742

 

5,137

 

Asset impairment loss

 

 

5,658

 

 

5,658

 

Restructuring

 

 

529

 

 

529

 

Total operating expenses

 

3,179

 

12,160

 

12,118

 

28,796

 

Loss from operations

 

(2,954

)

(11,653

)

(1,587

)

(26,760

)

Other income (expense):

 

 

 

 

 

 

 

 

 

Realized gain (loss) on sale of securities

 

(142

)

20

 

(142

)

142

 

Interest income

 

30

 

204

 

184

 

912

 

Interest expense

 

(57

)

(75

)

(177

)

(281